Buy One Get One free -Llimited Time Offer X
Imiwok is a prescription drug, available for use as Injection. Secondary and off-label uses of Imiwok have also been mentioned below.
The optimal dosage of Imiwok is largely dependent on the individual's body weight, medical history, gender and age. Individual symptoms and route of administration also determines the right dosage. For detailed information on this, read through the dosage section.
Apart from the aforementioned side effects, Imiwok can also lead to other problems, which have been listed below. Such side effects of Imiwok normally do not last long and go away once the treatment is completed. Consult your doctor if these side effects become worse or stay for a longer duration.
In addition, Imiwok's effect is Moderate during pregnancy and Moderate for lactating mothers. In addition, Imiwok's effects on the liver, heart and kidney are discussed below in the Imiwok related warnings section.
Imiwok can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Imiwok in conditions like Kidney Disease, Kidney Disease. Other conditions have been mentioned below in the Imiwok contraindications section.
Drug reaction of Imiwok with other medicines has been reported. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Imiwok is considered safe while driving, and is addictive.
Imiwok is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Adult |
|
Geriatric |
|
Infant (1 month to 2 years) |
|
Neonates (0 to 1 month) |
|
Based on research, the following side effects have been observed when Imiwok is used -
Severe
Moderate
Mild
Is the use of Imiwok safe for pregnant women?
Imiwok may cause moderate side effects during pregnancy. If you feel its harmful effects, then stop taking this drug immediately, and do not take Imiwok again without your doctor's advice.
Is the use of Imiwok safe during breastfeeding?
Imiwok can cause moderate side effects on breastfeeding women. If you feel its side effects, then stop taking this drug and consult your doctor. Take this medicine again only if your doctor advises to do so.
What is the effect of Imiwok on the Kidneys?
Imiwok may cause harmful effects on kidney. if you feel its having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Imiwok on the Liver?
Imiwok can have moderate side effects on the liver. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Imiwok on the Heart?
Side effects of Imiwok rarely affect the heart.
Imiwok should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Imiwok unless your doctor advises you to do so -
Is this Imiwok habit forming or addictive?
No, there is no any evidence that Imiwok is addictive.
Interaction between Food and Imiwok
Imiwok may take longer to act if you eat some foods while taking it. Follow your doctor's advice on this.
Interaction between Alcohol and Imiwok
Taking Imiwok with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Primaxin® (imipenem and cilastatin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 731
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 676-678